Long-Covid Patients Are Frustrated That Federal Research Hasn't Found New Treatments
Long-Covid Patients Are Frustrated That Federal Research Hasn't Found New Treatments
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
Along with claiming the lives of 1.2 million Americans, the covid-19 pandemic has been described as a mass disabling event.
Estimates of prevalence range considerably, depending on how researchers define long covid in a given study, but the Centers for Disease Control and Prevention puts it at 17 million adults.
Despite long covid’s vast reach, the federal government’s investment in researching the disease — to the tune of $1.15 billion as of December — has so far failed to bring any new treatments to market.